Flow cytometry–based basophil and mast cell activation tests in allergology: State of the art, 2025, Didier G. Ebo MD, PhD et al

Abstract
The major challenge in allergy diagnosis is development of accessible and reliable diagnostics that can predict the clinical outcome following exposure to culprit allergen(s) or cross-reactive molecules and identification of safer alternatives than the current state-of-the-art methods.

There is accumulating evidence that flow-based analyses for the quantification of activated basophils and mast cells subsequent to in vitro challenge (the basophil and mast cell activation test [BAT/MAT] or basophil activation test [BAT] and mast cell activation test [MAT]) could meet the diagnostic requirements for IgE-dependent allergies, drug hypersensitivities, and subsets of autoimmune urticaria.

Furthermore, the BAT and MAT have found application in research and other nondiagnostic fields. However, appropriate use of the BAT and MAT requires understanding of the diversity of the source materials used and degranulation metrics to ensure correct test performance and interpretation of results.

In this review, we provide the main applications and limitations of the BAT and MAT, as performed thus far.
LINK

Evidence suggests basophil and mast cell activation tests could meet the diagnostic requirements for IgE-dependent allergies and other conditions, but their use requires knowledge to ensure performance and interpret results.